Citadel Advisors’s Molecular Data Inc. American Depositary Shares MKD Stock Holding History

Citadel Advisors’s Portfolio MKD Stock Details MKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-27,603	Closed	-$15K	–	14301
2022 Q2	$15K	Buy	27,603 +19,889	+258%	+$28.7K	﹤0.01%	12508
2022 Q1	$23K	Buy	+7,714	New	+$21.6K	﹤0.01%	13215
2021 Q3	–	Sell	-11,292	Closed	-$158K	–	15149
2021 Q2	$158K	Sell	11,292 -7,213	-39%	-$96K	﹤0.01%	12447
2021 Q1	$299K	Buy	18,505 +15,306	+478%	+$286K	﹤0.01%	10866
2020 Q4	$40K	Buy	+3,199	New	+$52.4K	﹤0.01%	10655
2020 Q1	–	Sell	-4,258	Closed	-$305K	–	10441
2019 Q4	$305K	Buy	+4,258	New	+$327K	﹤0.01%	7556

Other funds holding MKD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Citadel Advisors's MKD Position: Q3 2022 in Review

Citadel Advisors sold out of Molecular Data Inc. American Depositary Shares (MKD) in Q3 2022, closing a stake of 27,603 shares — an estimated $15K sold.

Citadel Advisors first reported a position in MKD in Q4 2019 and held it in 6 quarters. The position peaked at $305K in Q4 2019. 2 funds tracked by Wall St. Rank hold MKD as of Q3 2022.

Citadel Advisors reported no remaining Molecular Data Inc. American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 27,603 Molecular Data Inc. American Depositary Shares shares in Q3 2022, an estimated $15K.
Citadel Advisors first reported a position in Molecular Data Inc. American Depositary Shares in Q4 2019 and held it in 6 quarters.
Citadel Advisors's Molecular Data Inc. American Depositary Shares position peaked at $305K in Q4 2019.
2 funds tracked by Wall St. Rank held Molecular Data Inc. American Depositary Shares as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.